ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "longitudinal studies"

  • Abstract Number: 1094 • ACR Convergence 2020

    Long Term Open Label Extension of Study of Tofacitinib in Refractory Dermatomyositis

    Julie Paik1, Jemima Albayda1, Eleni Tiniakou1, Grazyna Purwin1, Andrew Koenig2 and Lisa Christopher-Stine1, 1Johns Hopkins University, Baltimore, MD, 2Pfizer Inc, New York City, NY

    Background/Purpose: Tofacitinib is a pan-JAK inhibitor that demonstrated safety and efficacy in a 12 week open label trial of 10 subjects with refractory dermatomyositis (NCT03002649).…
  • Abstract Number: 1874 • ACR Convergence 2020

    Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis

    Mark Hwang1, Martin Rozycki2, Theresa Arndt2, Esther Yi3 and Michael Weisman4, 1McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 2HVH Precision Analytics, LLC, Wayne, PA, 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, 4Cedars Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA

    Background/Purpose: Healthcare claims databases can be used to identify patients with ankylosing spondylitis (AS) prior to diagnosis. This study explores differences in pathways to AS…
  • Abstract Number: 1160 • ACR Convergence 2020

    Treatment Intensity and Impact on Bone Lesion Evolution and Distribution Patterns in Severe Chronic Recurrent Multifocal Osteomyelitis

    Aleksander Lenert1, T. Shawn Sato2, Sedat G Kandemirli1, Patrick Ten Eyck1 and Polly Ferguson3, 1University of Iowa, Iowa City, IA, 2University of Iowa, Iowa City, 3University of Iowa Carver College of Medicine, Iowa City, IA

    Background/Purpose: To compare bone lesion evolution and bone lesion distribution patterns identified by whole body magnetic resonance imaging (WB-MRI) by treatment intensity in patients with…
  • Abstract Number: 1938 • ACR Convergence 2020

    Risk for Vision Loss and Relapse in Patients with Giant Cell Arteritis

    Anne Bull Haaversen1 and Andreas Diamantopoulos2, 1Martina Hansens Hospital, Hosle, Norway, 2Martina Hansens Hospital, Baerum, Norway

    Background/Purpose: Giant cell arteritis (GCA) involves both the cranial and large vessels. Studies have shown that while the vision loss rates are higher, the relapse…
  • Abstract Number: 1298 • ACR Convergence 2020

    Lupus Damage Free-Survival by Age at Diagnosis: A Retrospective Incident Lupus Cohort

    Maria Schletzbaum1, Nnenna Ezeh2, Trevor McKown3, Shivani Garg4 and Christie Bartels5, 1University of Wisconsin-Madison School of Medicine and Public Health, Department of Population Health Sciences, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Milwaukee, WI, 3William S. Middleton Memorial Veterans Hospital, Madison, WI, 4UW Madison, Madison, WI, 5University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI

    Background/Purpose: While medical comorbidities increase with age, younger age at onset of Systemic Lupus Erythematosus (SLE) has been associated with greater risk of some types…
  • Abstract Number: 1983 • ACR Convergence 2020

    Trajectories of Disease Activity in Patients with Newly Diagnosed Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

    Natalie Shiff1, Peter Shrader2, Colleen Correll3, Anne Dennos4, Thomas Phillips2 and Timothy Beukelman5, 1Florida, Gainesville, FL, 2Duke University, Durham, 3University of Minnesota, Minneapolis, MN, 4Duke University, Durham, NC, 5University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To describe data-derived 2-year trajectories of disease activity in patients with recently diagnosed juvenile idiopathic arthritis (JIA) as measured by the clinical Juvenile Arthritis…
  • Abstract Number: 120 • 2020 Pediatric Rheumatology Symposium

    Characteristics of the New Childhood Arthritis and Rheumatology Research Alliance Registry of Juvenile Myositis Patients Enrolled in the First Two Years

    Jessica Neely1, Adam Huber 2 and Susan Kim 3 for the CARRA investigators, 1University of California, San Francisco, San Francisco, California, 2IWK Health Centre & Dalhousie University, Halifax, Nova Scotia, Canada, 3University of California, San Francisco, San Francisco

    Background/Purpose: The New CARRA Registry of Juvenile Myositis (JM) was developed in 2017 to collect 10-year longitudinal data to increase knowledge of the course of…
  • Abstract Number: 139 • 2020 Pediatric Rheumatology Symposium

    Ongoing Disease Activity in Juvenile Idiopathic Arthritis (JIA) 18 Years After Disease Onset: A Population-based Nordic Study

    Mia Glerup1, Ellen D Arnstad 2, Veronika Rypdal 3, Suvi Peltoniemi 4, Kristiina Aalto 5, Marite Rygg 6, Susan Nielsen 7, Anders Fasth 8, Lillemor Berntson 9, Ellen Nordal 3 and Troels Herlin 10, 1Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Denmark, 2Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, and Department of Pediatrics, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway., Tromheim, Norway, 3Department of Pediatrics, University Hospital of North Norway, and Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Tromsø, Norway, 4Department of Pediatrics, New Children's Hospital, Helsinki University Hospital, Pediatric Research Center, University of Helsinki, Helsinki, Finland., Helsinki, Finland, 5Department of Pediatrics, New Children's Hospital, Helsinki University Hospital, Pediatric Research Center, University of Helsinki, Helsinki, Finland., HUS, Finland, 6Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology and Department of Pediatrics, St. Olavs Hospital, Trondheim, Norway., Trondheim, Norway, 7Department of Pediatrics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Copenhagen, Denmark, 8Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Gothenburg, Sweden, 9Department of Womens and Childrens Health, Uppsala University, Uppsala, Sweden., Uppsala, Sweden, 10Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark., Aarhus N, Denmark

    Background/Purpose: Previously, we showed that ILAR JIA categories defined at disease onset change considerably during the first 8 years of disease course. Whether achieved remission…
  • Abstract Number: 2890 • 2019 ACR/ARP Annual Meeting

    The Effect of Rheumatoid Arthritis and Biologics on the Acquisition of Subsequent Diseases and Adverse Events: A Matched Longitudinal Population Study

    Mark Tatangelo1, George Tomlinson 2, Edward Keystone 3, Michael Paterson 4, Nick Bansback 5 and Claire Bombardier 6, 1University of Toronto, Toronto, Canada, 2University of Toronto, Toronto, ON, Canada, 3Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, 4Institute for Clinical Evaluative Sciences, Toronto, Canada, 5University of British Columbia, Vancouver, Canada, 6Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: The direct and indirect effects of rheumatoid arthritis (RA) are difficult to measure in observational studies because: (1) The inflammatory effects of RA are…
  • Abstract Number: 188 • 2019 ACR/ARP Annual Meeting

    The Importance of Diagnosis: Clinical Distinctions Between Adult JIA and RA, and a Characterization of Patients with JIA Reclassified as RA in Adulthood

    Kristin Wipfler1, Sofia Pedro 1, Yomei Shaw 1, Rebecca Schumacher 1, Teresa Simon 2, Alyssa Dominique 3, Adam Reinhardt 4 and Kaleb Michaud 5, 1FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, 2Bristol-Myers Squibb*, Princeton, NJ, 3Bristol-Myers Squibb, Princeton, NJ, 4Children’s Hospital & Medical Center & University of Nebraska Medical Center, Omaha, NE, 5FORWARD, The National Databank for Rheumatic Diseases and University of Nebraska Medical Center, Wichita, KS

    Background/Purpose: Upon transitioning from pediatric to adult care, many patients with JIA are labeled as having RA, despite the two diagnoses being distinct in care…
  • Abstract Number: 604 • 2019 ACR/ARP Annual Meeting

    Do Illness Perceptions and Coping Change over Time in Patients Recently Diagnosed with Axial Spondyloarthritis? A 2-Year Follow-Up Study in the SPACE Cohort

    Miranda van Lunteren1, Robert B.M. Landewé 2, Camilla Fongen 3, Roberta Ramonda 4, Désirée van der Heijde 1 and Floris van Gaalen 1, 1Leiden University Medical Center, Leiden, Netherlands, 2Amsterdam University Medical Center, Amsterdam, Netherlands, 3Diakonhjemmet Hospital, Oslo, Norway, 4University of Padova, Padova, Italy

    Background/Purpose: We have previously shown that in patients with recently diagnosed axial SpA (axSpA), illness perceptions had a negative impact on the relationship between back…
  • Abstract Number: 647 • 2019 ACR/ARP Annual Meeting

    Is ANA-status at Disease Inception Associated with Long-term Damage Accrual and Direct and Indirect Health Care Costs in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort?

    May Choi1, Megan Barber 2, Marvin Fritzler 1, John G Hanly 3, Murray Urowitz 4, Yvan St-Pierre 5, Juanita Romero-Diaz 6, Caroline Gordon 7, Sang-Cheol Bae 8, Sasha Bernatsky 9, Daniel J Wallace 10, David A Isenberg 11, Anisur Rahman 12, Ellen M Ginzler 13, Michelle Petri 14, Ian Bruce 15, Paul Fortin 16, Dafna Gladman 17, Jorge Sanchez-Guerrero 18, Rosalind Ramsey-Goldman 19, Munther A Khamashta 20, Cynthia Aranow 21, Meggan Mackay 22, Graciela Alarcón 23, Susan Manzi 24, Ola Nived 25, Andreas Jönsen 25, Asad Zoma 26, Ronald van Vollenhoven 27, Manuel Ramos-Casals 28, Guillermo Ruiz-Irastorza 29, S Sam Lim 30, Kenneth C Kalunian 31, Murat Inanc 32, Diane Kamen 33, Christine Peschken 34, Soren Jacobsen 35, Anca Askanase 36, Vernon Farewell 37 and Ann E Clarke 38, 1Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2University of Calgary, Calgary, Canada, 3Dalhousie University, Halifax, NS, Canada, 4University Health Network, University of Toronto, Toronto, ON, Canada, 5McGill University Health Centre, Montreal, QC, Canada, 6Instituto Nacional de Ciencias Medicas y Nutricion Salvador, Zubiran Vasco de Quiroga, Mexico City, Mexico, 7University of Birmingham, Birmingham, United Kingdom, 8Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 9Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 10Cedars-Sinai Medical Centre, Beverly Hills, CA, 11Centre for Rheumatology, London, United Kingdom, 12University College London, London, United Kingdom, 13State University of New York Downstate Medical Center, Brooklyn, NY, 14Johns Hopkins University School of Medicine, Baltimore, MD, 15University of Manchester, Manchester, United Kingdom, Manchester, England, United Kingdom, 16Division de Rhumatologie, Département de Médecine, CHU de Québec – Université Laval, Axe maladies infectieuses et inflammatoires, Centre de recherche du CHU de Québec – Université Laval, Canada, Quebec, QC, Canada, 17University of Toronto, Toronto, ON, Canada, 18Toronto Western Hospital, Toronto, ON, Canada, 19Northwestern University, Chicago, IL, 20King's College London School of Medicine, London, United Kingdom, 21Feinstein Institute for Medical Research, Manhasset, NY, 22Feinstein Institute for Medical Research, New York, 23University of Alabama at Birmingham, Birmingham, 24Allegheny Health Network, Pittsburg, PA, 25Lund University, Lund, Sweden, 26Hairmyres Hospital, East Kilbride, United Kingdom, 27Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, the Netherlands, Amsterdam, Netherlands, 28Josep Font Autoimmune Diseases Laboratory, Barcelona, Spain, 29Autoimmune Diseases Unit, Hospital Universitario Cruces, Barakaldo, Spain, Barakaldo, Spain, 30Emory University, Atlanta, GA, 31UC San Diego School of Medicine, LaJolla, CA, 32Istanbul University, Istanbul, Turkey, 33Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, SC, 34University of Manitoba, Winnipeg, Canada, 35Copenhagen Lupus and Vasculitis Clinic, Copenhagen, Denmark, 36Columbia University Medical Center, New York, NY, 37University of Cambridge, Cambridge, United Kingdom, 38University of Calgary, Calgary, AB, Canada

    Background/Purpose: We reported that 7.7% (88/1137) of patients in an international inception cohort were ANA-negative at enrolment (Arthritis Care Res 2018 doi:1002/acr23712).  There are no…
  • Abstract Number: 1453 • 2019 ACR/ARP Annual Meeting

    Baseline EULAR Sjögren’s Syndrome Patient-Reported Index Has a Significant Impact on the Longitudinal Course of Sjögren’s Syndrome

    Eun Hye Park1, You-Jung Ha 1, Eun Ha Kang 1, Yeong-Wook Song 2 and Yun Jong Lee 3, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea, Seongnam, Republic of Korea, 2Seoul National University Hospital, Seoul, Republic of Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea, Seongnam, Republic of Korea

    Background/Purpose: The EULAR Sjögren's syndrome (SS) disease activity index (ESSDAI) and EULAR SS Patient-Reported Index (ESSPRI) have been validated as disease activity and outcome measures…
  • Abstract Number: 2080 • 2019 ACR/ARP Annual Meeting

    It Starts at Work: The Relationship Between Workplace Supports and Presenteeism Among Young Adults with Rheumatic Disease

    Arif Jetha1, Lori Tucker 2, Julie Bowring 3, Catherine L. Backman 4, Laurie Proulx 5, Vicki Kristman 6, Elizabeth M. Hazel 7, Louise Perlin 8 and Monique A.M. Gignac 3, 1Institute for Work & Health, Toronto, ON, Canada, 2British Columbia Children’s Hospital, Vancouver, Canada, 3Institute for Work & Health, Toronto, Canada, 4University of British Columbia, Vancouver, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada, 6Lakehead University, Thunder Bay, Canada, 7McGill University Health Centre, Montreal, Canada, 8St. Michael’s Hospital, Toronto, ON, Canada

    Background/Purpose: Young adults with rheumatic disease who are employed frequently report presenteeism (i.e., working while unwell). Workplace supports including extended health benefits, job accommodations and…
  • Abstract Number: 2411 • 2019 ACR/ARP Annual Meeting

    Casting a Wide Net: Comparing Strategies for Recruiting 18-35-year-olds with Rheumatic Disease as Study Participants

    Arif Jetha1, Lori Tucker 2, Julie Bowring 3, Catherine L. Backman 4, Laurie Proulx 5, Vicki Kristman 6 and Monique A.M. Gignac 3, 1Institute for Work & Health, Toronto, ON, Canada, 2British Columbia Children’s Hospital, Vancouver, Canada, 3Institute for Work & Health, Toronto, Canada, 4University of British Columbia, Vancouver, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada, 6Lakehead University, Thunder Bay, Canada

    Background/Purpose: Young adulthood is a unique life phase that spans 18-35 years, and is characterized by healthcare, educational, vocational and social transitions. Experiences in young…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology